跳至主要内容
临床试验/EUCTR2009-011817-26-BE
EUCTR2009-011817-26-BE进行中(未招募)1 期

A pilot study to assess the feasibility of unrelated umbilical cord blood transplantation with coinfusion of third-party mesenchymal stem cells after myeloablative or nonmyeloablative conditioning in adult patients with hematological malignancies.

Z Brussel VUB0 个研究点目标入组 20 人开始时间: 2009年9月28日最近更新:

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Patient inclusion criteria:
  • Age 15-60 yrs with following diseases
  • Allogeneic stem cell transplantation is the preferred treatment option:
  • High risk acute myeloid leukemia (AML) in first complete remission (CR)
  • High risk acute lymphoblastic leukemia (ALL) in first CR
  • Acute leukemia in second or third remission
  • High risk myelodysplastic syndrome: IPSS Intermediate-2 or high risk
  • Advanced lymphoproliferative disorders
  • Chronic myeloid leukemia
  • Multiple myeloma
  • Informed consent given
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Patient exclusion criteria
  • Previous allogeneic transplant
  • Progressive malignant disease
  • Significant organ damage as a contraindication to allotransplantation
  • Creatinine clearance < 60 ml/min
  • AST/ALT > 3x normal value and/or serum bilirubin > 3 mg/dL
  • Cardiac failure (LVEF < 50%)
  • Clinical relevant pulmonary disease: DLCO < 50% normal
  • Significant psychiatric or neurological disorder
  • Uncontrolled viral, fungal or bacterial infection
  • HIV positive

研究者

发起方
Z Brussel VUB

相似试验